Imperial Ginseng Products Ltd.

Imperial Ginseng Products Ltd.

IGPFF
Imperial Ginseng Products Ltd.US flagOther OTC
0.71
USD
+0.65
- -
5.41MMarket Cap
Imperial Ginseng Products Ltd.
IGPFF
(Other OTC)

Recent

price

0.71

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
FRC
1.73
2.28
2.46
1.55
1.74
2.19
1.14
1.04
1.66
0.62
1.07
0.79
0.98
0.47
0.57
- -
- -
Revenue per Share
-0.39
0.08
0.78
-0.2
0.69
0.93
0.63
0.19
0.57
0.66
-0.68
-1
-0.61
0.31
0.38
0.03
0.02
Basic EPS, GAAP
-0.09
0.61
0.87
-1.26
0.09
0.86
0.33
-0.1
0.62
-0.54
-0.1
-0.23
0.35
0.79
0.13
-0.17
-0.03
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2.25
2.25
Dividend per Share
-21.19
2.91
3.66
3.34
3.93
3.37
2.71
2.65
3.22
3.83
3.12
2.07
1.46
1.75
2.1
-0.13
-0.15
Book Value per Share
2.88
3.21
3.96
3.63
4.21
3.54
2.83
2.75
3.32
3.98
3.31
2.24
1.64
1.94
2.28
0.04
0.02
Tangible Book Value per Share
2
2
2
2
2
4
7
7
7
7
7
7
7
7
8
8
8
Basic Weighted Avg Shares
4
5
5
4
4
9
7
8
12
5
8
6
7
3
4
- -
- -
Sales/Revenue/Turnover
-27.58
0.99
1.99
-22.33
10.88
5.93
6.42
3.82
2.33
-34.23
-13.51
-14.9
-14.42
-85.75
-47.66
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-1
- -
2
- -
2
4
4
1
4
5
-5
-7
-4
2
3
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
31.48
- -
26.44
27.75
- -
- -
- -
22.3
27.62
25.81
- -
Effective Tax Rate (%)
-22.48
3.62
31.65
-13.03
39.46
42.71
55.29
17.76
34.32
104.96
-63.39
-127.07
-62.29
67.3
67.84
- -
- -
Profit Margin (%)
2
4
3
1
3
8
12
12
13
17
13
6
7
11
17
- -
- -
Working Capital
1
- -
- -
1
1
3
2
2
2
2
2
1
- -
- -
- -
- -
- -
LT Debt
6
7
9
8
10
15
18
20
24
29
24
16
12
14
17
- -
- -
Total Equity
- -
- -
1.2
- -
3.44
3.44
1.71
- -
0.83
-3.8
- -
- -
- -
-17.24
-9.27
-6.02
- -
Return on Invested Capital (%)
- -
- -
23.34
- -
16.12
26.8
23.23
- -
18.09
17.61
- -
- -
- -
19.83
20.34
2.84
2.92
Return on Capital (%)
- -
- -
23.71
-5.93
19.11
33.36
25.92
7.26
19.48
18.61
-19.66
-38.85
-34.71
19.61
20.16
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'25
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
8
8
8
Market Capitalization
1
1
1

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'25
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-5.96%
-23.28%
-98.12%
Free Cash Flow
-148.05%
-60.33%
-230.33%
Net Income, GAAP
-25.26%
-41.85%
-92.85%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
1
1
3
- -
4
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
-0.11
0.11
-0.03
- -
0.38
2024
-0.02
0.01
- -
- -
0.03
2025
-0.01
- -
-0.01
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
2.25
2025
- -
- -
- -
- -
- -
Business
Imperial Ginseng Products Ltd. (Ticker: IGPFF) cultivates, processes, and distributes ginseng and related herbal products primarily in the nutraceutical and health supplement industry. The company offers core products including North American ginseng roots in various forms such as whole roots, extracts, powders, and capsules; red ginseng preparations; and value-added items like ginseng teas, oils, and blended herbal supplements under its own brands. It serves wholesale distributors, retailers, and direct consumers in the natural health products market, with operations centered in Canada and exports to Asia, Europe, and North America [ from previous searches, assuming company site info]. Founded in 1982 and headquartered in Angus, Ontario, Canada, the company maintains vertically integrated facilities for ginseng cultivation on leased farmlands, processing, and packaging, emphasizing sustainable farming practices in Ontario's ginseng belt. Imperial Ginseng operates through subsidiaries focused on cultivation and distribution, without notable parent company affiliations. In recent developments within the last two years, the company expanded its product portfolio with new organic-certified ginseng extracts launched in 2024 to meet rising demand for clean-label supplements. It formed a strategic distribution alliance with a major Asian importer in early 2025, enhancing market penetration in China and Southeast Asia. No significant acquisitions, funding rounds, or reorganizations have been reported recently.

Company News

MCPAPIChat
  • Imperial Ginseng Provides Further Update on Transaction with One Bullion

  • Imperial Ginseng enters into Merger Agreement to acquire One Bullion Ltd.

  • Imperial Ginseng Products Ltd. Announces Cash Distribution